New Technique Provides Microscopic Images of Suspicious Polyps During Colonoscopy

News from Digestive Disease Week 2008

A tiny microscope, less than one-sixteenth of an inch, attached to the end of the instrument used for a colonoscopy can provide magnified pictures of cells and small blood vessels in suspicious lesions allowing doctors to make on-the-spot decisions about whether a polyp is benign or precancerous.

The technique — confocal endomicroscopy — can identify benign polyps 98 percent of the time, avoiding having to remove the lesion and wait for results of the biopsy.  Precancerous polyps can be viewed, identified, and treated immediately during the colonoscopy.

Mayo Clinic researchers, Dr. Michael Wallace and Dr. Anna Buchner, presented their findings at Digestive Disease Week in San Diego this May.

After studying differences in benign and precancerous colon polyps, they used the new system to classify 37 polyps in 25 patients.  The lesions were then removed and diagnosed by pathologists.  The confocal endomicroscopy system was 89 percent accurate in identifying whether polyps were precancerous or benign.  Even better, it accurately identified 98 percent of benign polyps.

In a news release from the Mayo  Clinic, Dr. Wallace said,

Today, half of all polyps surgically removed during colonoscopy procedures are benign, and so this virtual biopsy will save time and expense, and reduce complications that can occur.

Dr. Buchner is working toward 100 percent accuracy in classifying benign polyps that don’t need to be removed for a pathologist’s scrutiny.  She says,

That is what you want in a device like this. Removing a polyp that looks precancerous, but turns out to be benign, is okay, but you don’t want to leave polyps intact in the colon that are actually cancerous. This probe is almost perfectly reliable in that regard and with more experience I am sure we can improve accuracy to nearly 100 percent.

SOURCE: Buchner et al., High Resolution Confocal Endomicroscopy Probe System for in vivo Diagnosis of Colorectal Neoplasia (Late Breaking Abstract), Digestive Disease Week 2008.

Bookmark and Share

This news article was originally posted on June 5th, 2008 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Kate Murphy on June 5th, 2008
Tags: colonoscopy, Digestive Disease Week

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe